Home > News > Nanosphere's newest detector zeros in on specific diseases
January 7th, 2004
Nanosphere's newest detector zeros in on specific diseases
Abstract:
Nanosphere Inc., a privately held life sciences company headquartered in Northbrook, Ill., is adding protein detection capabilities to its line of nanotech-based molecular detection tools. Developed by Northwestern University researcher and Nanosphere co-founder Chad Mirkin, the new technique uses gold nanoparticles and short strands of “barcode” DNA to detect the presence of disease-specific molecules in the human body.
Source:
SmallTimes
Related News Press |
Products
Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018
Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018
Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018
Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||